Baird Financial Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.1M | Sell |
251,697
-82,443
| -25% | -$6.35M | 0.03% | 393 |
|
|
2025
Q4 | $26.5M | Buy |
334,140
+12,309
| +4% | +$970K | 0.04% | 298 |
|
|
2025
Q3 | $24.3M | Buy |
321,831
+24,029
| +8% | +$1.65M | 0.04% | 324 |
|
|
2025
Q2 | $20.5M | Buy |
297,802
+11,099
| +4% | +$728K | 0.04% | 354 |
|
|
2025
Q1 | $19.4M | Buy |
286,703
+34,485
| +14% | +$2.06M | 0.04% | 358 |
|
|
2024
Q4 | $11.3M | Sell |
252,218
-177,263
| -41% | -$9.94M | 0.02% | 485 |
|
|
2024
Q3 | $27M | Sell |
429,481
-170,587
| -28% | -$9.95M | 0.05% | 288 |
|
|
2024
Q2 | $35.4M | Sell |
600,068
-66,214
| -10% | -$4.14M | 0.07% | 240 |
|
|
2024
Q1 | $53.1M | Sell |
666,282
-8,864
| -1% | -$677K | 0.11% | 199 |
|
|
2023
Q4 | $53.3M | Buy |
675,146
+7,891
| +1% | +$562K | 0.12% | 196 |
|
|
2023
Q3 | $46.6M | Sell |
667,255
-149,248
| -18% | -$10.6M | 0.13% | 177 |
|
|
2023
Q2 | $56.4M | Sell |
816,503
-14,121
| -2% | -$1M | 0.15% | 157 |
|
|
2023
Q1 | $61.7M | Buy |
830,624
+4,266
| +0.5% | +$358K | 0.15% | 154 |
|
|
2022
Q4 | $77M | Sell |
826,358
-24,348
| -3% | -$2.35M | 0.2% | 109 |
|
|
2022
Q3 | $81.1M | Sell |
850,706
-13,900
| -2% | -$1.38M | 0.24% | 95 |
|
|
2022
Q2 | $80.1M | Sell |
864,606
-6,340
| -0.7% | -$619K | 0.22% | 102 |
|
|
2022
Q1 | $88.1M | Sell |
870,946
-35,218
| -4% | -$3.7M | 0.22% | 102 |
|
|
2021
Q4 | $93.5M | Sell |
906,164
-21,722
| -2% | -$2.01M | 0.22% | 105 |
|
|
2021
Q3 | $78.7M | Sell |
927,886
-25,330
| -3% | -$2.12M | 0.2% | 130 |
|
|
2021
Q2 | $79.5M | Sell |
953,216
-24,665
| -3% | -$2.02M | 0.21% | 126 |
|
|
2021
Q1 | $73.6M | Buy |
977,881
+15,683
| +2% | +$1.14M | 0.21% | 122 |
|
|
2020
Q4 | $65.7M | Buy |
962,198
+27,342
| +3% | +$1.78M | 0.2% | 135 |
|
|
2020
Q3 | $54.6M | Buy |
934,856
+8,422
| +0.9% | +$524K | 0.19% | 146 |
|
|
2020
Q2 | $60.2M | Buy |
926,434
+11,299
| +1% | +$712K | 0.23% | 120 |
|
|
2020
Q1 | $54.3M | Sell |
915,135
-56,003
| -6% | -$3.74M | 0.25% | 101 |
|
|
2019
Q4 | $72.1M | Sell |
971,138
-38,414
| -4% | -$2.7M | 0.26% | 97 |
|
|
2019
Q3 | $63.7M | Sell |
1,009,552
-1,385,373
| -58% | -$82.1M | 0.25% | 102 |
|
|
2019
Q2 | $130M | Buy |
2,394,925
+1,729,183
| +260% | +$93.1M | 0.51% | 39 |
|
|
2019
Q1 | $35.9M | Buy |
665,742
+377,954
| +131% | +$23.3M | 0.21% | 138 |
|
|
2018
Q4 | $18.9M | Buy |
287,788
+23,745
| +9% | +$1.77M | 0.13% | 201 |
|
|
2018
Q3 | $21M | Sell |
264,043
-9,245
| -3% | -$661K | 0.13% | 192 |
|
|
2018
Q2 | $17.6M | Sell |
273,288
-11,786
| -4% | -$777K | 0.12% | 205 |
|
|
2018
Q1 | $17.7M | Buy |
285,074
+120,007
| +73% | +$8.61M | 0.12% | 204 |
|
|
2017
Q4 | $12M | Sell |
165,067
-66,878
| -29% | -$4.86M | 0.08% | 249 |
|
|
2017
Q3 | $18.9M | Sell |
231,945
-3,698
| -2% | -$293K | 0.14% | 181 |
|
|
2017
Q2 | $19M | Sell |
235,643
-36,114
| -13% | -$2.85M | 0.15% | 176 |
|
|
2017
Q1 | $21.3M | Sell |
271,757
-11,373
| -4% | -$908K | 0.17% | 162 |
|
|
2016
Q4 | $22.3M | Buy |
283,130
+39,709
| +16% | +$3.21M | 0.19% | 150 |
|
|
2016
Q3 | $21.7M | Buy |
243,421
+15,809
| +7% | +$1.49M | 0.19% | 148 |
|
|
2016
Q2 | $21.9M | Buy |
227,612
+19,568
| +9% | +$1.95M | 0.2% | 148 |
|
|
2016
Q1 | $21.6M | Buy |
208,044
+32,297
| +18% | +$3.14M | 0.21% | 143 |
|
|
2015
Q4 | $17.2M | Buy |
175,747
+11,474
| +7% | +$1.12M | 0.17% | 163 |
|
|
2015
Q3 | $15.8M | Buy |
164,273
+19,139
| +13% | +$2.01M | 0.17% | 159 |
|
|
2015
Q2 | $15.2M | Buy |
+145,134
| New | +$14.8M | 0.15% | 171 |
|
Other funds holding CVS
VCM
VPM
Baird Financial Group's CVS Position: Q1 2026 in Review
Baird Financial Group reduced its CVS Health (CVS) stake by 25% in Q1 2026, selling an estimated $6.35M and leaving 251,697 shares worth $18.1M. The position accounts for 0.03% of the portfolio, ranked #393.
Baird Financial Group first reported a position in CVS in Q2 2015 and has held it in 44 quarters since. The position peaked at $130M in Q2 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Baird Financial Group held 251,697 shares of CVS Health worth $18.1M as of Q1 2026.
- Baird Financial Group sold 82,443 CVS Health shares in Q1 2026, an estimated $6.35M.
- CVS Health made up 0.03% of Baird Financial Group's portfolio in Q1 2026, its #393 holding.
- Baird Financial Group first reported a position in CVS Health in Q2 2015 and has held it in 44 quarters since.
- Baird Financial Group's CVS Health position peaked at $130M in Q2 2019.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.